Update

Search This Blog

Biogen’s Alzheimer’s drug is unlikely to win E.U. approval.

November 17, 2021

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

By Rebecca Robbins | NYTimes NYT > World > Europe | Disclosure

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Comments

From New England to Notre-Dame, a U.S. Carpenter Tends to a French Icon

Hank Silver, a timber framer based in Massachusetts, is one of a handful of foreigners who are helping to rebuild the Paris cathedral after the devastating fire in 2019. By Aurelien Breeden | NYTimes NYT > World > Europe | Disclosure

Coaches Have to Be Salesmen, Too

David Moyes has established West Ham as a fixture in the top half of the Premier League and a regular presence in Europe. So why do so many fans want him out? By Rory Smith | NYTimes NYT > World > Europe | Disclosure

For Sale: A Rare Klimt Portrait, Valued at $32 Million. But of Whom?

The painting’s re-emergence after decades has come with a swirl of questions about its subject, one of three related teenage girls. By Scott Reyburn | NYTimes NYT > World > Europe | Disclosure

Turkey Earthquake Trial Opens Amid Anger and Tears

More than 300 people were killed when temblors toppled an upscale residential complex. Survivors hope a court will punish the men who built it. By Safak Timur and Ben Hubbard | NYTimes NYT > World > Europe | Disclosure

In an Unusual Vote, Democrats Rescue Measure to Allow Vote on Ukraine Bill

A resolution to pave the way for the foreign aid package was on track to die in committee amid Republican opposition when Democrats stepped in to save it. By Catie Edmondson | NYTimes NYT > World > Europe | Disclosure

Biogen’s Alzheimer’s drug is unlikely to win E.U. approval.

Comments

Post a Comment